About iScience Interventional
iScience Interventional is a Healthcare company based in Menlo Park (United States) founded in 1999, and was acquired by Ellex in January 2014. Microcatheter and imaging technologies for ophthalmic procedures are developed. iScience Interventional has raised $36.68 million across 7 funding rounds from investors including Medtronic, Square 1 Bank and Indiana University Health. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is ISCIENCE INTERVENTIONAL CORP. Its competitors include Kodiak Sciences, Second Sight and Eyedaptic; 3 of its 3 listed competitors have raised funding.
Company details
iScience Interventional was founded in 1999 in Menlo Park, United States, focusing on medical devices for ophthalmology. Microcatheter, microcannula, and imaging technologies were developed, including the iTRACK microcatheter, ViscoInjector for canaloplasty, iLumin portable laser diode light source, and iUltraSound imaging product. Operations centered on tools for ophthalmologists until acquisition by Ellex in 2014.
- Headquarters Menlo Park, United States
- Stage Acquired
- SectorsHealthcare
- Website iscienceinterventional.com
- Social LinkedIn
- Acquired by Ellex (Jan 2014)
- Legal Name Iscience Interventional Corp
Funding Insights of iScience Interventional
iScience Interventional has successfully raised a total of $36.68M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5 million completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.68M
- Total Rounds 7
- Last Round Debt – Conventional — $5M
- First Round $20.5M
(Apr 2009)
- Investors Count 10
All 7 funding rounds of iScience Interventional with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2012 | $5M | Debt – Conventional | – | – | |
| Jan 2012 | $2.76M | Series F | – | – | – |
| Oct 2011 | Series F | – | Medtronic | – | |
| Aug 2011 | $3M | Series F | – | – | – |
| May 2011 | $5.34M | Series F | – | – | – |
| Sep 2010 | $5.09M | Series F | – | – | – |
| Apr 2009 | $20.5M | Series F | – | Affinity Capital Management, Johnson & Johnson Innovation – JJDC |
11 investors in total: 11 institutional.
Investors in iScience Interventional
iScience Interventional has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Square 1 Bank and Indiana University Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| affinitycapitalmanagement.com | ||||
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
| lcapitalpartners.com | ||||
VC firm investing in the US | prismventure.com | Westwood, United States | ||
Life science & tech focused VC firm investing in companies in the US | threearchpartners.com | San Mateo, United States | ||
| denovovc.com | ||||
Early-stage US companies are invested in by Asset Management Ventures. | assetman.com | Palo Alto, United States | ||
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
Healthcare services are delivered through hospitals in Indiana. | 1997 | iuhealth.org | Indianapolis, United States |
Investor details for iScience Interventional
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of iScience Interventional
4 dated milestones of iScience Interventional across 15 years, from founding to its latest funding, stage changes and deals.
- Founded iScience Interventional is founded.
- Funding First funding round of $20.5M.
- Funding Latest funding round, Debt – Conventional, of $5.0M.
- Exit Acquired by Ellex.
Competitors of iScience Interventional
iScience Interventional has 3 listed competitors in our database, 3 of them funded. They include Kodiak Sciences, Second Sight and Eyedaptic.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kodiak.com | 2009 | Palo Alto, United States | $35.84M | 112 | Therapeutics for retinal diseases are developed by the company. | |
| secondsight.com | 2000 | Los Angeles, United States | $52.3M | 14 | Implantable visual prosthetics for blind individuals are developed and provided. | |
| eyedaptic.com | 2016 | Laguna Niguel, United States | $1.42M | A wearable augmented reality vision assistance solution |
Detailed competitors of iScience Interventional
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as iScience Interventional (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Iscience Interventional
Complete news archive for iScience Interventional
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iScience Interventional
iScience Interventional was founded in 1999 and raised its 1st funding round 10 years after it was founded.
iScience Interventional is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
iScience Interventional is a funded company, having raised a total of $36.68M across 7 funding rounds to date. The company's 1st funding round was a Series F of $20.5M, raised on Apr 2009.
iScience Interventional was founded in 1999 in Menlo Park, United States, focusing on medical devices for ophthalmology. Microcatheter, microcannula, and imaging technologies were developed, including the iTRACK microcatheter, ViscoInjector for canaloplasty, iLumin portable laser diode light source, and iUltraSound imaging product. Operations centered on tools for ophthalmologists until acquisition by Ellex in 2014.
iScience Interventional's top competitors include Kodiak Sciences, Second Sight and Eyedaptic.
iScience Interventional has 11 investors. Key investors include Medtronic, Square 1 Bank, Indiana University Health, Ellex, and Affinity Capital Management.
iScience Interventional operates through Iscience Interventional Corp.
Yes. iScience Interventional was acquired by Ellex in January 2014.